MedTrace Logo

Interest in "Combo" (a Combination of Dietary Supplements Including Probiotics) in NASH Improvement

NCT04781933 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2023-11-07

No results posted yet for this study

Summary

The aim of this bicentre, prospective, placebo-controlled, double-blind, randomized, interventional study is to assess for the first time the effects of a Combo with probiotics and dietary supplements compared to placebo for non-alcoholic steatohepatitis (NASH) patients with mild or severe fibrosis.

Conditions

  • NASH - Nonalcoholic Steatohepatitis

Interventions

DIETARY_SUPPLEMENT

Treatment with Combo

Treatment with Combo

OTHER

Treatment with placebo

Treatment with placebo

Sponsors & Collaborators

  • Mativa-Tech SA

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-01-01
Primary Completion
2024-01-01
Completion
2025-01-01

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04781933 on ClinicalTrials.gov